The US government can continue to press its case alleging AIMA Business and Medical Support LLC defrauded Medicare by billing the health-care program for genetic laboratory tests that weren’t medically necessary.
The government’s False Claims Act complaint pleaded fraud with adequate detail because it included sample Medicare claims for various patients with claim submission dates, test descriptions, and payment amounts, Chief Judge
The government says AIMA, a UK and India-based business-process outsourcing company, worked with a ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.